The Indian Phase Ⅲ Clinical Trial Training of MEBO is Initiated

For the purpose of completing the registration of MEBO and publicizing the BRT of Human Body Regenerative Restoration Science in India, Pro.Chen Yongchong who is the Member of Chinese Burn Association of the Integration of Traditional and Western Medicine (CBAIM) , clinical director of China National Science & Technology Center for Burns, Wounds and Ulcers, Vice president of Beijing RongXiang Institution of Burns, Wounds and Ulcers and the Technical Supporter Zhang Yin of MEBO International Group, invited by the Indian cooperator Huclin Research Limited, were dispatched by MEBO International Group to give trainings on the clinical doctors of the five clinical trial centers about the clinical protocol, the general routine of BRT in treating burns and the standard method to change dressing.

In the morning of 23ed, September, Pro.Chen and Technical Supporter Zhang Yin were invited by Dr. Kannan the CEO of Huclin Research Limited to visit the head office. During the visit, the two sides have discussed some technical problems of the clinical protocol in detail and reached to an agreement and framed a complete plan for the clinical trial. Meanwhile, Pro.Chen gave a special lecture about the BRT in the treatment of burns, wounds and ulcers during the visit. The staff of the head office was deeply attracted by the clinical efficacy of BRT and was shocked by what the BRT has achieved at the present stage and its future development prospect. The CEO Dr.Kannan is very confident about completing the clinical trial successfully and promoting the MEBO Indian market. In the afternoon, accompanied by the manager of marketing department Mr.Nagaraju, Prof.Chen and Technical Supporter Zhang Yin visited the headquarters of Regenix Corporate and met with Dr.A.Ramamurthy the chairman of Huclin and Regenix. During the meeting, Dr. A.Ramamurthy deployed the training plan personally, which guaranteed the whole clinical trial trainings go smoothly and successfully. 

CEO Dr.Kannan explaining clinical protocol      Pro.Chen illustrating general operation routine of BRT in treating burns

After training Pro.Chen visiting the ICU of Deepan Nursing Home      Pro.Chen demonstrating general operation routine of BRT

Pro.Chen giving training on the chief investigator Dr. A.Sivakumar
Meeting with former chairman of South Indian Burn Association Pro. G.Balakrishnan at Right Hospital in Chennai

From 23rd, September to 30th, September, Pro.Chen and Technical Supporter Zhang Yin visited the B.G.Hospital in Tutocorin which located in the Southernmost part of India, the Deepan Nursing Home in Tiruchirapalli, Omshakthi Hospital in Dharmapuri, Right Hospital and Abhijay Hospital in Chennai and gave trainings on the clinical investigators of each centre about the clinical protocol, the general operation routine of BRT in treating burns and the standard method to change dressing. In the process of training, CEO Dr. Kannan first introduced the important points and the matters need attention of the clinical protocol. Then, Pro.Chen gave a lecture on the BRT, the general operation routine of BRT in treating burns and the standard method to change dressing. Many doctors and nurses heard about the BRT for the first time and they were very interested in it and were excited by what the BRT has successfully achieved in treating burns, wounds and ulcers. After training, many doctors and nurses could not help to express that ‘The technique of BRT not only has brought gospel to Chinese burn patients, but also will bring gospel to the burn patients of India and all over the world’. Those doctors and nurses wish the BRT&MEBT/MEBO to be brought into India as soon as possible in order to benefit the burns, wounds and ulcers patients of India.

The clinical trial centers covers the hospitals in three levels- provincial level, municipal level, county level, which gives a overall cover of different groups of people and will benefit the success of MEBO registration and audit in the DCGI(Drug Controller General India). This training provided forceful support for the success of Indian Phase Ⅲ clinical trial which will be started on 14th, October and also publicized and promoted the BRT of Human Body Regenerative Restoration Science in India, which will contribute to the all-round popularization and promotion of BRT/MEBT&MEBO in Indian market after completing MEBO registration in DCGI.